ID SYI_CHLMU Reviewed; 1036 AA. AC Q9PL20; DT 27-APR-2001, integrated into UniProtKB/Swiss-Prot. DT 01-OCT-2000, sequence version 1. DT 28-JAN-2026, entry version 137. DE RecName: Full=Isoleucine--tRNA ligase {ECO:0000255|HAMAP-Rule:MF_02003}; DE EC=6.1.1.5 {ECO:0000255|HAMAP-Rule:MF_02003}; DE AltName: Full=Isoleucyl-tRNA synthetase {ECO:0000255|HAMAP-Rule:MF_02003}; DE Short=IleRS {ECO:0000255|HAMAP-Rule:MF_02003}; GN Name=ileS {ECO:0000255|HAMAP-Rule:MF_02003}; GN OrderedLocusNames=TC_0288; OS Chlamydia muridarum (strain MoPn / Nigg). OC Bacteria; Pseudomonadati; Chlamydiota; Chlamydiia; Chlamydiales; OC Chlamydiaceae; Chlamydia/Chlamydophila group; Chlamydia. OX NCBI_TaxID=243161; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=MoPn / Nigg; RX PubMed=10684935; DOI=10.1093/nar/28.6.1397; RA Read T.D., Brunham R.C., Shen C., Gill S.R., Heidelberg J.F., White O., RA Hickey E.K., Peterson J.D., Utterback T.R., Berry K.J., Bass S., RA Linher K.D., Weidman J.F., Khouri H.M., Craven B., Bowman C., Dodson R.J., RA Gwinn M.L., Nelson W.C., DeBoy R.T., Kolonay J.F., McClarty G., RA Salzberg S.L., Eisen J.A., Fraser C.M.; RT "Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae RT AR39."; RL Nucleic Acids Res. 28:1397-1406(2000). CC -!- FUNCTION: Catalyzes the attachment of isoleucine to tRNA(Ile). As IleRS CC can inadvertently accommodate and process structurally similar amino CC acids such as valine, to avoid such errors it has two additional CC distinct tRNA(Ile)-dependent editing activities. One activity is CC designated as 'pretransfer' editing and involves the hydrolysis of CC activated Val-AMP. The other activity is designated 'posttransfer' CC editing and involves deacylation of mischarged Val-tRNA(Ile). CC {ECO:0000255|HAMAP-Rule:MF_02003}. CC -!- CATALYTIC ACTIVITY: CC Reaction=tRNA(Ile) + L-isoleucine + ATP = L-isoleucyl-tRNA(Ile) + AMP + CC diphosphate; Xref=Rhea:RHEA:11060, Rhea:RHEA-COMP:9666, Rhea:RHEA- CC COMP:9695, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:58045, CC ChEBI:CHEBI:78442, ChEBI:CHEBI:78528, ChEBI:CHEBI:456215; EC=6.1.1.5; CC Evidence={ECO:0000255|HAMAP-Rule:MF_02003}; CC -!- COFACTOR: CC Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000255|HAMAP- CC Rule:MF_02003}; CC -!- SUBUNIT: Monomer. {ECO:0000255|HAMAP-Rule:MF_02003}. CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_02003}. CC -!- DOMAIN: IleRS has two distinct active sites: one for aminoacylation and CC one for editing. The misactivated valine is translocated from the CC active site to the editing site, which sterically excludes the CC correctly activated isoleucine. The single editing site contains two CC valyl binding pockets, one specific for each substrate (Val-AMP or Val- CC tRNA(Ile)). {ECO:0000255|HAMAP-Rule:MF_02003}. CC -!- SIMILARITY: Belongs to the class-I aminoacyl-tRNA synthetase family. CC IleS type 2 subfamily. {ECO:0000255|HAMAP-Rule:MF_02003}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AE002160; AAF39156.1; -; Genomic_DNA. DR PIR; F81719; F81719. DR RefSeq; WP_010230051.1; NC_002620.2. DR AlphaFoldDB; Q9PL20; -. DR SMR; Q9PL20; -. DR GeneID; 1246458; -. DR KEGG; cmu:TC_0288; -. DR eggNOG; COG0060; Bacteria. DR HOGENOM; CLU_001493_1_1_0; -. DR OrthoDB; 9810365at2; -. DR Proteomes; UP000000800; Chromosome. DR GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell. DR GO; GO:0002161; F:aminoacyl-tRNA deacylase activity; IEA:InterPro. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule. DR GO; GO:0004822; F:isoleucine-tRNA ligase activity; IEA:UniProtKB-UniRule. DR GO; GO:0000049; F:tRNA binding; IEA:InterPro. DR GO; GO:0008270; F:zinc ion binding; IEA:UniProtKB-UniRule. DR GO; GO:0006428; P:isoleucyl-tRNA aminoacylation; IEA:UniProtKB-UniRule. DR CDD; cd07961; Anticodon_Ia_Ile_ABEc; 1. DR CDD; cd00818; IleRS_core; 1. DR FunFam; 3.40.50.620:FF:000241; Isoleucine--tRNA ligase; 1. DR FunFam; 3.40.50.620:FF:000133; Isoleucyl-tRNA synthetase, cytoplasmic; 1. DR Gene3D; 3.40.50.620; HUPs; 2. DR Gene3D; 1.10.730.10; Isoleucyl-tRNA Synthetase, Domain 1; 1. DR Gene3D; 3.90.740.10; Valyl/Leucyl/Isoleucyl-tRNA synthetase, editing domain; 1. DR HAMAP; MF_02003; Ile_tRNA_synth_type2; 1. DR InterPro; IPR001412; aa-tRNA-synth_I_CS. DR InterPro; IPR002300; aa-tRNA-synth_Ia. DR InterPro; IPR033709; Anticodon_Ile_ABEc. DR InterPro; IPR002301; Ile-tRNA-ligase. DR InterPro; IPR023586; Ile-tRNA-ligase_type2. DR InterPro; IPR013155; M/V/L/I-tRNA-synth_anticd-bd. DR InterPro; IPR014729; Rossmann-like_a/b/a_fold. DR InterPro; IPR009080; tRNAsynth_Ia_anticodon-bd. DR InterPro; IPR009008; Val/Leu/Ile-tRNA-synth_edit. DR NCBIfam; TIGR00392; ileS; 1. DR PANTHER; PTHR42780:SF1; ISOLEUCINE--TRNA LIGASE, CYTOPLASMIC; 1. DR PANTHER; PTHR42780; SOLEUCYL-TRNA SYNTHETASE; 1. DR Pfam; PF08264; Anticodon_1; 1. DR Pfam; PF19302; DUF5915; 1. DR Pfam; PF00133; tRNA-synt_1; 1. DR PRINTS; PR00984; TRNASYNTHILE. DR SUPFAM; SSF47323; Anticodon-binding domain of a subclass of class I aminoacyl-tRNA synthetases; 2. DR SUPFAM; SSF52374; Nucleotidylyl transferase; 1. DR SUPFAM; SSF50677; ValRS/IleRS/LeuRS editing domain; 1. DR PROSITE; PS00178; AA_TRNA_LIGASE_I; 1. PE 3: Inferred from homology; KW Aminoacyl-tRNA synthetase; ATP-binding; Cytoplasm; Ligase; Metal-binding; KW Nucleotide-binding; Protein biosynthesis; Reference proteome; Zinc. FT CHAIN 1..1036 FT /note="Isoleucine--tRNA ligase" FT /id="PRO_0000098527" FT MOTIF 46..56 FT /note="'HIGH' region" FT MOTIF 589..593 FT /note="'KMSKS' region" FT BINDING 592 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|HAMAP-Rule:MF_02003" SQ SEQUENCE 1036 AA; 118950 MW; 69E6B05FD54D5E8D CRC64; MDNEDKVSFP AKEEKVLTFW KEQNIFQKTL ENRDGSPTFS FYDGPPFATG LPHYGHLLAG TIKDVVCRYA TMDGHYVPRR FGWDCHGVPV EYEVEKSLGL TEPGAIDRFG IANFNEECRK IVFRYVDEWK YFVDRIGRWV DFSATWKTMD LSFMESVWWV FHSLYKQGLV YEGTKVVPFS TKLGTPLSNF EAGQNYKEVD DPSVVAKFAL QDDQGILLAW TTTPWTLVSN MALAVHPGLT YVRIQDKESG EEYILGQESL ARWFPDRESY KWIGQLSGES LVGRRYCPLF PYFQDQQDRG AFRVIPADFI EESEGTGVVH MAPAFGEADF FACQEHNVPL VCPVDNQGCF TSEVTDFVGE YIKFADKGIA RRLKNENKLF YQGTIRHRYP FCWRTDSPLI YKAVNSWFVS VEKVKHKMLK ANESIHWTPG HIKHGRFGKW LEGARDWAIS RNRYWGTPIP IWRSEDGELL VIRSIQELEE LSGQKIVDLH RHFIDEIVIH KNGKSFHRIP YVFDCWFDSG AMPYAQNHYP FERAEETEAR FPADFIAEGL DQTRGWFYTL TVIAAALFDQ PAFKNVIVNG IVLAEDGNKM SKRLNNYPSP KKIMDTYGAD ALRLYLLNSV VVKAEDLRFS DKGVEAVLKQ VLLPLSNALA FYKTYAELYG FSPNETTDLE LAEIDRWILS SLYSLVGKTR ENMAQYDLHA AVSPFIDFIE DLTNWYIRRS RRRFWESEDS PDRRAAFATL YEVLMVFSKI IAPFIPFTAE DMYQQLRVET DPESVHLCDF PHVVLEKILP DLEKKMQDIR EIVALGHSLR KEHKLKVRQP LQHMYIVGAK ERMAALAQVD SLIGEELNVK EVHFCSETPE YVTTLVKPNF RSLGKRVGNR LPEIQKALAG LSQEQIQAFM HNGFMVLSLG EETISLNEED ITVSWEAAPG FVARSSASFV AILDCQLTSP LIMEGIAREI VNKINTMRRN GKLHVSDRIA IRLHAPKIVQ EAFSQYEEYI CEETLTTSVS FIDDKEGEEW DVNGHAVSLS LEVIGH //